[Sinus vein thrombosis. A rare complication of heparin-induced thrombocytopenia type II].
In the past 10 years numerous reports of cases referring to complications and their outcome with heparin-induced thrombocytopenia type II (HIT II) have been published. Clinically these symptoms are manifested as a combination of arterial and venous thromboembolisms. Mostly affected are the vessels of the limbs, the abdomen, kidneys and coronary arteries. We present the most rare initial manifestations of cerebral symptoms with headache, nausea, change of character and generalised convulsion, which have found their origin in sinus vein thrombosis and the treatment with the heparinoid danaparoid.
Merz
S
S
Klinik für Anästhesiologie und Intensivmedizin, Klinikum der Stadt Villingen-Schwenningen GmbH. Merz-SUD@swol.de
Fehr
R
R
Gülke
C
C
D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects*; D000927:Anticonvulsants / Q000627:therapeutic use; D001772:Blood Cell Count; D002809:Chondroitin Sulfates / Q000627:therapeutic use; D003871:Dermatan Sulfate / Q000627:therapeutic use; D004338:Drug Combinations; D006493:Heparin / Q000009:adverse effects*; D006497:Heparan Sulfate / Q000627:therapeutic use; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000209:etiology; D011183:Postoperative Complications / Q000628:therapy; D012640:Seizures / Q000188:drug therapy / Q000209:etiology; D012851:Sinus Thrombosis, Intracranial / Q000000981:diagnostic imaging / Q000209:etiology* / Q000601:surgery; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000150:complications*; D014057:Tomography, X-Ray Computed
D000925:Anticoagulants; D000927:Anticonvulsants; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D004338:Drug Combinations; D006493:Heparin; D006497:Heparan Sulfate; C035838:danaparoid